glp-1 diarrhea GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Understanding the Side Effects of
Description
Most adverse events were mild to moderate gastrointestinal events, primarily occurring during the dose-escalation period
It is not genetics, though genetics play a role
These studies uniformly showed that Liraglutide significantly reduced body weight when used as an adjunct therapy with diet and exercise
off-label for weight loss
Natural strategies, such as diet, exercise, and gut health support, work by encouraging the body to produce GLP-1 on its own.
